EVAX

MKT CAP:$33M

Evaxion Biotech AS

Market Cap

$33M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$3.55-$1.16 (-24.63%)

Jun 5, 2026

52W High $11.0152W Low $2.07

Company Details

Evaxion A/S, a clinical-stage biotech company, develops artificial intelligence-powered immunology vaccines. The company develops EVX-01, which is in phase 2 global multi-center clinical trial for the treatment of advanced melanoma; EVX-03,...

CEO

—

IPO Date

Feb 5, 2021

Website

evaxion.ai

Key Metrics TTM

Revenue

$8M

+121.1% YoY

Net Income

-$10M

EPS (Diluted)

Free Cash Flow

-$7M

Revenue / Share

$0.91

Gross Margin

0.0%

Operating Margin

-121.7%

Net Margin

-129.3%

FCF Margin

-88.2%

P/S

4.3x

P/E

Earnings Reports

Q1 2026

Mar 31, 2026

$0-100.0%

FY 2025

Mar 5, 2026

$8M+125.1%

Q4 2025

Mar 5, 2026

$22.0K-81.9%

Q3 2025

Nov 6, 2025

$7M+148.3%

Q2 2025

Aug 14, 2025

$37.0K-76.0%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee